🏥 治験ポータル

← 治験一覧に戻る

黄色ブドウ球菌ネットワーク適応プラットフォーム試験

基本情報

NCT ID: NCT05137119
ステータス: 募集中
試験のフェーズ: 第4相
試験タイプ: 介入
目標被験者数: 8,000
治験依頼者名: University of Melbourne

概要

The Staphylococcus aureus Network Adaptive Platform (SNAP) trial is an International Multi-Centered Randomised Adaptive Platform Clinical Trial to evaluate a range of interventions to reduce mortality for patients with Staphylococcus Aureus bacteraemia (SAB).

対象疾患

Staphylococcus Aureus Bacteremia

介入

Cefazolin(DRUG)

Penicillin(DRUG)

Clindamycin(DRUG)

Vancomycin(DRUG)

Effectiveness of early switch to oral antibiotics(OTHER)

Whole body FDG PET/CT Imaging(RADIATION)

依頼者（Sponsor）

King's College London(OTHER)

Tan Tock Seng Hospital(OTHER)

Sunnybrook Health Sciences Centre(OTHER)

The Methodist Hospital Research Institute(OTHER)

Rambam Health Care Campus(OTHER)

University College, London(OTHER)

Berry Consultants(OTHER)

Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre(OTHER)

The Peter Doherty Institute For Infection And Immunity(OTHER)

Telethon Kids Institute(OTHER)

The University Of Queensland(OTHER)

Queensland University Of Technology(OTHER)

Aotearoa Clinical Trials(UNKNOWN)

Menzies School Of Health Research(OTHER)

Umc Utrecht(OTHER)

University Of Melbourne(OTHER)

Radboud University Medical Center(OTHER)

実施施設 (1)

東京科学大学　保健管理センター　湯島保健管理センター

Ichikawa, Chiba, Japan(RECRUITING)